Social Anxiety Disorder Clinical Trial
— SCE-CBTOfficial title:
A Randomized Controlled Trial on the Efficacy of Self-Compassion Enhanced CBT vs. Standard CBT for Social Anxiety
| Verified date | July 2018 |
| Source | Babes-Bolyai University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This study evaluates the addition of a self-compassion training in the treatment of social anxiety disorder. Half of the participants will receive a self-compassion enhanced group cognitive-behavioral therapy, while the other half will receive standard group cognitive-behavioral therapy.
| Status | Completed |
| Enrollment | 60 |
| Est. completion date | January 2018 |
| Est. primary completion date | July 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - subjects diagnosed with Social Anxiety Disorders using the DSM-5 criteria - subjects that have SAD as the primary diagnosis according to DSM-5 criteria - exceed the cutoff scores on SPIN, SIAS, and LSAS-SR Exclusion Criteria: - subjects that score over 29 points at BDI-II - display suicidal ideation (i.e., exceed a score of 2 on the suicide item of BDI-II) - undergo other forms of treatment for SAD - have a diagnosis of psychosis, bipolar disorder or personality disorders according to DSM-5 criteria |
| Country | Name | City | State |
|---|---|---|---|
| Romania | Babes-Bolyai University | Cluj-Napoca | Cluj |
| Lead Sponsor | Collaborator |
|---|---|
| Babes-Bolyai University |
Romania,
Fergus TA, Valentiner DP, McGrath PB, Jencius S. Shame- and guilt-proneness: relationships with anxiety disorder symptoms in a clinical sample. J Anxiety Disord. 2010 Dec;24(8):811-5. doi: 10.1016/j.janxdis.2010.06.002. Epub 2010 Jun 11. — View Citation
Gilbert, P, Miles, JNV.Sensitivity to social put-down: Its relationship to perceptions of social rank, shame, social anxiety, depression, anger and self-other blame. Personality and Individual Differences, 29: 757-774, 2000.
Gilbert, P, Procter, S. Compassionate mind training for people with high shame and self-criticism: Overview and pilot study of a group therapy approach. Clinical Psychology and Psychotherapy, 13(6): 353-379, 2006.
Gilbert, P.The relationship of shame, social anxiety and depression: The role of the evaluation of social rank. Clin Psychol Psychother, 7: 174-189, 2000.
Hedman E, Ström P, Stünkel A, Mörtberg E. Shame and guilt in social anxiety disorder: effects of cognitive behavior therapy and association with social anxiety and depressive symptoms. PLoS One. 2013 Apr 19;8(4):e61713. doi: 10.1371/journal.pone.0061713. Print 2013. — View Citation
Heimberg, RG, & Becker, RE. Cognitive-behavioral group therapy for social phobia: Basic mechanisms and clinical strategies. Guilford Press, 2002.
Lutwak, N, Ferrari, JR.. Shame-related social anxiety: Replicating a link with various social interaction measures. Anxiety, stress, and coping, 10(4): 335-34, 1997.
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Changes in social anxiety symptoms using (Liebowitz Social Anxiety Scale; Leibowitz, 1987) | Self-reported measure of social anxiety symptoms | (1) baseline; (2) weekly for 11 weeks starting with the second week of treatment (2) at the of end of treatment (12 weeks after the start of the treatment) ; (3) 6 months after the end of treatment | |
| Primary | Changes in social anxiety symptoms using SPIN (Social Phobia Inventory; Connor et al., 2000) | Self-reported measure of social anxiety symptoms | (1) baseline; (2) after 6 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment | |
| Primary | Changes in social anxiety symptoms using SIAS (Social Interaction Anxiety Scale; Mattick & Clarke, 1998) | Self-reported measure of social anxiety symptoms | (1) baseline; (2) after 6 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment | |
| Primary | Changes in shame-proneness using TOSCA-3 (Test of Self-Conscious Affect-3; Tangney, Dearing, Wagner, & Gramzow, 2000) | Self-reported measure of predisposition to experience shame | (1) baseline; (2) after 3, 6, 9 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of the treatment | |
| Primary | Changes in social anxiety disorder clinical status | DSM-5 semi-structured interview for social anxiety disorder | at the end of the therapy | |
| Secondary | Changes in self-compassion using SCS (Self-Compassion Scale; Neff, 2003) | Self-reported measure of self-compassion | (1) baseline; (2) after 6 weeks from the start of the treatment; (2)at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment | |
| Secondary | Changes in self-compassion using SCSs (Self-Compassion Scale Short Form; Raes et al., 2011) | Self-reported measure of self-compassion | (1) baseline; (2) weekly for 11 weeks starting with the second week of treatment (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment | |
| Secondary | Changes in depressive symptoms using BDI-II (Beck Depression Inventory-II; Beck, 1996) | Self-reported measure of depressive symptoms | (1) baseline; (2) after 6 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment | |
| Secondary | Changes in positive and negative affect using PANAS (Positive and Negative Affect Schedule; Watson & Clark, 1999) | Self-reported measure of positive and negative affect | (1) baseline; (2) weekly for 11 weeks starting with the second week of treatment (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment | |
| Secondary | Changes in positive and negative emotions using PDA (Profile of Affective Distress; Opri? & Macavei, 2005) | Self-reported measure of positive and negative emotions | (1) baseline; (2) after 6 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment | |
| Secondary | Changes in irrational and rational thinking using ABS-II (Attitudes and Beliefs Scale- 2; DiGiuseppe, Leaf, Exner, & Robin, 1988) | Self-reported measure of rational and irrational beliefs | (1) baseline; (2) after 6 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment | |
| Secondary | Changes in emotion regulation using ERQ (Emotion Regulation Questionnaire; Gross & John, 2003) | Self-reported measure of the use of suppression and reappraisal | (1) baseline; (2) after 6 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment | |
| Secondary | Changes in emotion regulation using DERS (Difficulties in Emotion Regulation Scale; Gratz & Roemer, 2004) | Self-reported measure on emotion regulation strategies | (1) baseline; (2) after 6 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment | |
| Secondary | Changes in rational and irrational beliefs using GABS (General Attitudes and Beliefs Scale; Bernard, 1998) | Self-reported measure of rational and irrational beliefs | (1) baseline; (2) after 6 weeks from the start of the treatment; (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment | |
| Secondary | Changes in social phobia related thoughts using BFNE (Brief Fear of Negative Evaluation Scale; Leary, 1983) | Self-reported measure of social phobia relevant negative thoughts | (1) baseline; (2) weekly for 11 weeks starting with the second week of treatment (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment | |
| Secondary | Changes in shame with PFQ-2 (Personal Feelings Questionnaire-2; Harder & Zalma, 1990) | Self-reported measure of shame | (1) baseline; (2) weekly for 11 weeks starting with the second week of treatment (2) at the of end of treatment (12 weeks after the start of the treatment); (3) 6 months after the end of treatment |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06274112 -
Using TMS to Understand Neural Processes of Social Motivation
|
N/A | |
| Completed |
NCT02554929 -
Treatment of Social Anxiety Disorder and Selective Mutism
|
N/A | |
| Completed |
NCT00684541 -
Interpretation Modification Program for Social Phobia
|
N/A | |
| Completed |
NCT00684320 -
Attention Disengagement Training for Social Phobia
|
N/A | |
| Completed |
NCT03247075 -
Internet-delivered CBT vs Internet-delivered Support and Counseling for Youth With Social Anxiety Disorder - An RCT
|
N/A | |
| Completed |
NCT02811458 -
Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders
|
N/A | |
| Withdrawn |
NCT04622930 -
Waitlist-Control Trial of Smartphone CBT for Social Anxiety Disorder (SAD)
|
N/A | |
| Active, not recruiting |
NCT05018312 -
Modified Collaborative Assessment VS Standard Assessment on Readiness For Psychotherapy Among Patients With Anxiety
|
N/A | |
| Active, not recruiting |
NCT05124639 -
Clinical Trial of a Group Self-management Support Program for Anxiety Disorders
|
N/A | |
| Completed |
NCT05858294 -
The Safety, Acceptability and Efficacy of Alena
|
N/A | |
| Active, not recruiting |
NCT05600114 -
Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder
|
Phase 2 | |
| Not yet recruiting |
NCT06081348 -
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
|
Phase 2 | |
| Not yet recruiting |
NCT02924610 -
Brief Intervention to Reduce Fear
|
Phase 4 | |
| Active, not recruiting |
NCT02592564 -
Brain Plasticity and Cellular Aging After Internet-delivered CBT for Social Anxiety Disorder
|
N/A | |
| Recruiting |
NCT02305537 -
Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment
|
N/A | |
| Terminated |
NCT03764644 -
Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders
|
N/A | |
| Unknown status |
NCT01712321 -
Study of Vilazodone to Treat Social Anxiety Disorder
|
N/A | |
| Completed |
NCT01320800 -
CBT for Social Anxiety Disorder Delivered by School Counselors
|
Phase 2 | |
| Completed |
NCT00485888 -
Flushing in Social Anxiety Disorder on Cipralex
|
Phase 2 | |
| Completed |
NCT00485615 -
An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia
|
Phase 2 |